GlassScriptPhysician profile
Polina Sawyer
NPI 1245657725
$4,481.52
in general payments reported to CMS, 2019-2025
17 companies · $1,002 in 2025
The $1,002 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2022: $534 · 2023: $704 · 2024: $2,109 · 2025: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,780 · Travel and Lodging: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,780.23 |
| Travel and Lodging | $1,035.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,667.90 | 2022-2024 | Axonics, Bulkamid |
| Caldera Medical, INC | $965.37 | 2022-2025 | Desara |
| Coloplast Corp | $294.58 | 2022-2025 | Altis |
| Abbvie INC. | $253.21 | 2023-2025 | Botox |
| Femselect INC. | $238.37 | 2025 | Enplace |
| Bluewind Medical | $185.63 | 2024 | Revi |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Medical Device Business Services, INC. | $129.54 | 2023 | |
| Coopersurgical, INC. | $119.16 | 2025 | Onetrac Lx |
| Boston Scientific Corporation | $117.66 | 2022-2025 | Advantage System, Solyx Sis System, Axonics |
| Medtronic, INC. | $112.60 | 2022-2025 | Interstim |
| Sumitomo Pharma America, INC. | $58.79 | 2023-2025 | Gemtesa |
| 180 Medical, INC. | $57.18 | 2022-2023 | Cure Catheter |
| Smith+Nephew, INC. | $56.63 | 2024-2025 | Stravix Pl, Grafix Pl |
| Baxter Healthcare | $41.08 | 2024 | Perclot |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $36.54 | 2025 | |
| Astellas Pharma US INC | $15.55 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Polina Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.